These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38831285)

  • 1. Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population.
    Mazhnaya A; Geurts B; Brigida K; Bakieva S; Sadirova S; Witzigmann A; Musabaev E; Brandl M; Weishaar H; Dudareva S; Bcheraoui CE
    BMC Public Health; 2024 Jun; 24(1):1482. PubMed ID: 38831285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
    Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informing the design of a national screening and treatment programme for chronic viral hepatitis in primary care: qualitative study of at-risk immigrant communities and healthcare professionals.
    Sweeney L; Owiti JA; Beharry A; Bhui K; Gomes J; Foster GR; Greenhalgh T
    BMC Health Serv Res; 2015 Mar; 15():97. PubMed ID: 25890125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach.
    Ayakaka I; Ackerman S; Ggita JM; Kajubi P; Dowdy D; Haberer JE; Fair E; Hopewell P; Handley MA; Cattamanchi A; Katamba A; Davis JL
    Implement Sci; 2017 Mar; 12(1):33. PubMed ID: 28274245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
    Serumondo J; Penkunas MJ; Niyikora J; Ngwije A; Kiromera A; Musabeyezu E; Umutesi J; Umuraza S; Musengimana G; Nsanzimana S
    BMC Public Health; 2020 Jun; 20(1):946. PubMed ID: 32546216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators of adherence to awake prone positioning: a qualitative study using the COM-B model.
    Zhu L; Ni Z; Zhang Y; Zhan Y; Lan M; Zhao R
    BMC Pulm Med; 2023 Jul; 23(1):267. PubMed ID: 37468848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the COM-B model to barriers and facilitators to chlamydia testing in general practice for young people and primary care practitioners: a systematic review.
    McDonagh LK; Saunders JM; Cassell J; Curtis T; Bastaki H; Hartney T; Rait G
    Implement Sci; 2018 Oct; 13(1):130. PubMed ID: 30348165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.
    Howell J; Pedrana A; Cowie BC; Doyle J; Getahun A; Ward J; Gane E; Cunningham C; Wallace J; Lee A; Malani J; Thompson A; Hellard ME
    J Gastroenterol Hepatol; 2019 Jan; 34(1):40-48. PubMed ID: 30151932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to the integration of mental health services into primary healthcare: a qualitative study among Ugandan primary care providers using the COM-B framework.
    Wakida EK; Obua C; Rukundo GZ; Maling S; Talib ZM; Okello ES
    BMC Health Serv Res; 2018 Nov; 18(1):890. PubMed ID: 30477492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators.
    Jafar TH; Ramakrishnan C; John O; Tewari A; Cobb B; Legido-Quigley H; Sungwon Y; Jha V
    BMC Nephrol; 2020 Jan; 21(1):26. PubMed ID: 31996168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.
    Shiferaw F; Letebo M; Bane A
    BMC Public Health; 2016 Aug; 16(1):769. PubMed ID: 27514515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of Hepatitis B, C and D in Germany: A scoping review.
    Steffen G; Sperle I; Leendertz SA; Sarma N; Beermann S; Thamm R; Bremer V; Zimmermann R; Dudareva S
    PLoS One; 2020; 15(3):e0229166. PubMed ID: 32150561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP).
    Musabaev E; Estes C; Sadirova S; Bakieva S; Brigida K; Dunn R; Kottilil S; Mathur P; Abutaleb A; Razavi-Shearer K; Anstiss T; Yusupaliev B; Razavi H
    Liver Int; 2023 Apr; 43(4):773-784. PubMed ID: 36606729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the barriers and facilitators to the acceptability of donor human milk in eastern Uganda - a qualitative study.
    Magowan S; Burgoine K; Ogara C; Ditai J; Gladstone M
    Int Breastfeed J; 2020 Apr; 15(1):28. PubMed ID: 32303270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
    Ndejjo R; Mukama T; Kiguli J; Musoke D
    BMJ Open; 2017 Jun; 7(6):e016282. PubMed ID: 28606908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
    Versfeld A; McBride A; Scheibe A; Spearman CW
    Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Contextual Analysis to Explore Barriers and Facilitators of Pain Management in Swiss Nursing Homes.
    Brunkert T; Simon M; Ruppen W; Zúñiga F
    J Nurs Scholarsh; 2020 Jan; 52(1):14-22. PubMed ID: 31898860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.
    Datchoua Moukam AM; Embolo Owono MS; Kenfack B; Vassilakos P; Petignat P; Sormani J; Schmidt NC
    Reprod Health; 2021 Jul; 18(1):147. PubMed ID: 34243778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators of integrated hepatitis B, C, and HIV screening among pregnant mothers and their newborns attending maternal and newborn clinics in Koboko District, Uganda: A qualitative inquiry of providers' perspective.
    Alege JB; Oyore JP; Nanyonga RC; Musoke P; Orago ASS
    Res Sq; 2023 Dec; ():. PubMed ID: 38196577
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.